Design Therapeutics (DSGN) Short-term Investments: 2020-2021

Historic Short-term Investments for Design Therapeutics (DSGN) over the last 1 years, with Sep 2021 value amounting to $36.1 million.

  • Design Therapeutics' Short-term Investments was N/A to $36.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $36.1 million, marking a year-over-year change of. This contributed to the annual value of $33.7 million for FY2020, which is N/A change from last year.
  • According to the latest figures from Q3 2021, Design Therapeutics' Short-term Investments is $36.1 million, which was up 12.68% from $32.0 million recorded in Q2 2021.
  • Over the past 5 years, Design Therapeutics' Short-term Investments peaked at $36.1 million during Q3 2021, and registered a low of $10.6 million during Q1 2021.
  • Over the past 2 years, Design Therapeutics' median Short-term Investments value was $32.9 million (recorded in 2020), while the average stood at $28.1 million.